In this study, combination therapy recovered IL-12/IFN-γ positive feedback mechanisms and induced immune cell infiltration in TME, through removing restriction of cytokines by suppressing gal-3, meanwhile, shutting down the PD-L1 function of tumor cells by inhibition of immune checkpoint. This evidence concerns the gene LGALS3 and neoplasm.